![UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS) - Bird - 2009 - UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS) - Bird - 2009 -](https://onlinelibrary.wiley.com/cms/asset/ffecafce-1521-4793-a94e-a59e10701706/bjh_7807_f1.gif)
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS) - Bird - 2009 -
Monoclonal Gammopathy of Undetermined Significance (MGUS), Asymptomatic Multiple Myeloma, and Amyloidosis
![Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-019-0263-z/MediaObjects/41408_2019_263_Fig1_HTML.png)
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_JFP_06407_ArticleW1_t3.jpg.jpg)
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
![When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2022/edbk.2022.42.issue-1/edbk_349643/20220707/images/large/edbk_349643_table1.jpeg)
When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book
![IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma](https://pub.mdpi-res.com/ijms/ijms-20-02822/article_deploy/html/images/ijms-20-02822-g001.png?1571663357)
IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
![Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbmt.2011.244/MediaObjects/41409_2012_Article_BFbmt2011244_Fig1_HTML.jpg)